Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Blood|January 14, 2021
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cellsPaul J Collins, Christopher P Fox, Lindsay George, et al.
Plos Pathogens|May 17, 2012
Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biologyEmily Heath, Noelia Begue-Pastor, Sridhar Chaganti, et al.
The Journal of Bone and Joint Surgery. American Volume|November 18, 2016
Final Fusion After Growing-Rod Treatment for Early Onset Scoliosis: Is It Really Final?Connie Poe-Kochert, Claire Shannon, Jeff B Pawelek, et al.
Ebiomedicine|August 30, 2019
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancersLivingstone Fultang, Silvia Panetti, Margaret Ng, et al.
Plos Pathogens|February 17, 2021
Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoidsNina Wallaschek, Saskia Reuter, Sabrina Silkenat, et al.
Plos Pathogens|June 27, 2009
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycleNathan P Croft, Claire Shannon-Lowe, Andrew I Bell, et al.
Blood Advances|October 5, 2020
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphomaNenad Sejic, Lindsay C George, Rosemary J Tierney, et al.
Blood|October 10, 2015
Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventDavid M Burns, Rose Tierney, Claire Shannon-Lowe, et al.
Nucleic Acids Research|September 10, 2014
NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomasRoser Vento-Tormo, Javier Rodríguez-Ubreva, Lorena Di Lisio, et al.
The Journal of General Virology|July 22, 2020
A novel antiviral formulation inhibits a range of enveloped virusesNicola F Fletcher, Luke W Meredith, Emma L Tidswell, et al.
Pageof 5